Pharmaceutical company asks SEC to investigate website allegations
US pharmaceutical company Valeant has called on the US Securities and Exchange Commission to investigate Citron Research, after the stock commentary website said that it had uncovered accounting fraud at Valeant, according to reports.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.